Navigation Links
Rigel Announces Third Quarter 2011 Financial Results
Date:11/1/2011

SOUTH SAN FRANCISCO, Calif., Nov. 1, 2011 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the third quarter and nine months ended September 30, 2011.

For the third quarter of 2011, Rigel reported a net loss of $17.9 million, or $0.25 per basic and diluted share, compared to a net income of $50.4 million, or $0.97 and $0.96 per basic and diluted share, respectively, in the same period of 2010. Basic weighted average shares outstanding for the third quarters of 2011 and 2010 were 71.2 million and 52.1 million, respectively. Diluted weighted average shares outstanding for the third quarters of 2011 and 2010 were 71.2 million and 52.8 million, respectively.

Contract revenue for the third quarter of 2011 was $4.4 million, which included a payment of $4.3 million received in the quarter from Merck Serono S.A. and the remaining $0.1 million related to the upfront payment Rigel received for out-licensing its oncology program in June 2011. The collaboration agreement between Rigel and Merck Serono was terminated in 2010 and the program has been returned in full to Rigel. Rigel does not expect to record any further revenue from Merck Serono pursuant to the terminated collaboration agreement. Contract revenue in the third quarter of 2010 was $72.3 million from AstraZeneca AB (AZ), which included amortization of the upfront payment for the exclusive worldwide license agreement for fostamatinib, as well as revenue Rigel earned under that agreement for the initiation of the Phase 3 clinical trial program for fostamatinib and the transfer of the fostamatinib open label extension study to AZ.

Rigel reported total operating expenses of $22.4 million in the third quarter of 2011, compared to $21.9 million in the same period of 2010. The slight increase in operating expenses was primarily due t
'/>"/>

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Rigel to Present at Two Upcoming Investor Conferences
2. Rigel to Present at Wells Fargo Securities Healthcare Conference
3. Rigel to Present at Jefferies Global Healthcare Conference
4. Rigel Announces Pricing of Public Offering of Common Stock
5. Rigel Announces Proposed Public Offering of Common Stock
6. Rigel to Present at Bank of America Merrill Lynch Health Care Conference
7. Rigel Announces First Quarter Financial Results
8. Rigel Announces Fourth Quarter and Year End 2010 Financial Results
9. Rigel to Present at Three Upcoming Investor Conferences
10. Rigel Announces Participation at Two Investor Conferences
11. Rigel to Present at JP Morgan Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... Apr. 16, 2015 Research and Markets ... "Corporate Reputation of Pharma in 2014 - a ... report to their offering. For the ... on the corporate reputation of the pharmaceutical industry held ... with the views of patient organisations representing all therapy ...
(Date:4/16/2015)... Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ... commercialization of products for the treatment of central nervous ... the first quarter of 2015 on Wednesday, May 6, ... Company will host a conference call at 4:30 PM ... management will discuss the first quarter 2015 financial results ...
(Date:4/16/2015)...  Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) will report ... Wednesday, May 6, 2015, following the close of the U.S. ... call and live webcast on the same day at 5:00 ... the financial results.  To access the webcast ... "Investors" link.  Please log onto the webcast prior to the ...
Breaking Medicine Technology:Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 2Corporate Reputation of Pharma in 2014 - The Perspective of Mental Health Patient Groups - 1st Edition 3Vanda Pharmaceuticals to Announce First Quarter 2015 Financial Results on May 6, 2015 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 2Alexza to Report 2015 First Quarter Financial Results and Provide Corporate Update on Wednesday, May 6, 2015 3
... 2011 Unilife Corporation ("Unilife" or the "Company") (Nasdaq: ... be presenting at Cowen and Company,s 31st Annual Health Care ... Boston. Alan Shortall, Chief Executive Officer of Unilife, is scheduled ... 2011. The conference presentation will be broadcast over ...
... VICTOR, N.Y., March 7, 2011 PharmaNova, Inc. ... whereby Lacerta Bio,s experienced team of business development ... and U.K. to support its 2011 business growth ... PharmaNova,s partnering base for its innovative, nanoparticle technology, ...
Cached Medicine Technology:Unilife to Present at the 31st Annual Cowen Health Care Conference on Wednesday, March 9, 2011 in Boston 2PharmaNova Fuels Business Growth with Lacerta Bio Partnership 2
(Date:4/17/2015)... From the day Dr. Todd Phillips founded The Last ... empowered young people to create meaningful change in their world. ... and the Gospel to all of Liberia by 2020 , ... 27, students, faculty and staff raised $21,000 through the TEN ... the Good News of Jesus. , During the campaign, ...
(Date:4/17/2015)... Representatives Jim Himes (D-CT) and Ed Royce ... 1849 in congress on April 16, 2015 in an ... with the genetic disease. , The bill, similar ... first to create a federally led and financed initiative ... telangiectasia. This would effectively prevent premature death and disability ...
(Date:4/17/2015)... Hollywood, California (PRWEB) April 17, 2015 ... Durkin Entertainment’s EcoLuxe Lounge and the “Salute to the ... the luxurious Beverly Hilton Hotel, overlooking the impressive Los ... nominees were organized by Debbie Durkin, LA’s leading producer ... , Showcasing many of the world’s premier providers of ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 Baptist Health ... have signed a partnership agreement designed to transform oncology ... The institutions have agreed to create a joint cancer ... protocols and translational research. Baptist MD Anderson Cancer Center ... providing a single destination for highly coordinated, multidisciplinary cancer ...
(Date:4/17/2015)... 2015 The American College of Traditional Chinese Medicine ... Day on April 29. The event will be held from 11 ... 555 DeHaro St. in San Francisco, CA. , The agenda for ... at the DeHaro campus (room F), 11:10 a.m. – Introduction ... – Light lunch with current students, faculty and staff, 1 p.m. ...
Breaking Medicine News(10 mins):Health News:The Last Well and Liberty U’s TEN Initiative raises $21,000 to Bring Fresh Water & The Gospel to 7,000 Liberians 2Health News:House Representatives Introduce Bill to Fight Genetic Disease 2Health News:Choices Recovery Speaks with Dakota Hood of “The Hunger Games” about Addiction in Hollywood 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 3Health News:American College of Traditional Chinese Medicine Hosts Open House 2
... For patients with,rheumatoid arthritis, combining one well-known, lower ... works best to reduce joint,swelling or tenderness, according to ... and Quality, part of the U.S. Department of Health ... be posted on-line,Monday in the Annals of Internal Medicine., ...
... Minn., Nov. 19 Regions Hospital today was,named one ... care based on the Cardiovascular Benchmarks for Success,Study by ... 100 hospital comes as a result of the hard ... with the,excellent care provided to patients and an investment ...
... guide development, scientists say , MONDAY, Nov. 19 (HealthDay News) ... embryonic cells regulate levels of retinoic acid, a derivative of ... embryo development, acting as a signal between cells to control ... embryos that get too much or too little retinoic acid ...
... 19 Smith & Nephew,s,(NYSE: SNN ) (LSE: ... business to InaVein LLC, a Boston-area investor group led ... medical,device marketplace. Terms of the sale were not disclosed. ... product portfolio,as part of Smith & Nephew,s overall Earnings ...
... OMCL ) a leading provider of systems and ... today announced that Randall A. Lipps, chairman, president &,CEO ... at the Piper Jaffray,19th Annual Health Care Conference at ... scheduled to begin at 12:00 p.m. on Wednesday,November 28, ...
... different than men,s way beyond their reproductive systems. Women wake ... and are more likely to suffer from depression and sleep ... , Yet, there,s a cavernous void in research based ... on men and the findings applied to women. , ...
Cached Medicine News:Health News:Combining Medications Often Best Strategy to Battle Rheumatoid Arthritis 2Health News:Combining Medications Often Best Strategy to Battle Rheumatoid Arthritis 3Health News:Research Reveals Nutrient's Impact on the Embryo 2Health News:Smith & Nephew Endoscopy Announces the Sale of its Vascular Business 2Health News:Smith & Nephew Endoscopy Announces the Sale of its Vascular Business 3Health News:Omnicell to Present at Piper Jaffray 19th Annual Health Care Conference 2Health News:Women aren't men 2Health News:Women aren't men 3
The RU is a low profile implantable bipolar tined permanent pacing lead for stimulation of either the atrium (J model) or the ventricle (straight model)....
The Petite leads are low profile (4.8F lead body diameter) implantable endocardial pacing leads which are manufactured using a new proprietary hexafilar coil for permanent stimulation of the ventricl...
The Vitatron Excellence S+ lead series are endocardial leads providing excellent reliability and optimal pacing characteristics....
... Impulse II lead series are silicon ... extend the longevity of the pacemaker ... The high impedance of the lead ... electrode surface, combined with the elution ...
Medicine Products: